Mirena 52 MG systems
Ended Awarded Last action
- Contract number
- SPE2DR26FGGQ5
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,475
Award facts
- Contract value 100% obligated
- $5,474.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $5,474.80 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Mirena 52 mg contraceptive systems. The award was issued on February 4, 2026, with an ultimate completion date of February 26, 2026, under a firm fixed-price arrangement with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy that establishes multiple regional prime vendor contractors to support recurring pharmaceutical supply needs for Department of Defense healthcare operations.
DMS Pharmaceutical Group has demonstrated substantial federal contracting capability since its registration in the System for Award Management in 2001, with extensive experience distributing a comprehensive portfolio of branded and generic prescription medications, biologics, vaccines, and specialty pharmaceuticals to military healthcare facilities. The company's parent IDC under PPV-G GEN V, designated as contract SPE2DR and awarded on November 13, 2025, carries a ceiling value of $499,999,999 with a completion date of December 31, 2036, positioning the firm as a critical supplier within the federal military pharmaceutical supply chain. No subcontractors are identified in this award documentation.
Quick answers
Who was awarded contract SPE2DR26FGGQ5?
SPE2DR26FGGQ5 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26FGGQ5 worth?
The government has obligated $5,475 on SPE2DR26FGGQ5.
Is contract SPE2DR26FGGQ5 an order under another contract?
Yes. SPE2DR26FGGQ5 is a delivery order under SPE2DR25D9349, an indefinite delivery contract.
Was contract SPE2DR26FGGQ5 competed?
The extent of competition for SPE2DR26FGGQ5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award